ULBI ULTRALIFE CORP Insider Trading

Director Bradford T Whitmore bought 108,878 shares at blended $6.57 over 3 days; 5.6% portfolio increase amid unprofitable operations.

Director Bradford T Whitmore executed three separate purchases totaling 108,878 shares for $715,313.54 between 2026-05-21 and 2026-05-26, raising his holdings from 1,941,759 to 2,050,637 shares. The company's latest quarterly financials show revenue of $47,445,000.00 against net income of -$451,000.00, with annual revenue growth of +16.2% but full-year profitability still negative. At his prior trades at ULBI, 4 of 5 buys were well-timed at the 90-day mark, suggesting pattern recognition in his purchase timing at this ticker. The current stock price of $6.86 sits 27.9% below the 52-week high of $9.52 and down 9.1% over the past 30 days, though up 16.6% over 90 days—positioning this purchase in the context of recent price volatility and moderate-term gains.

ULBI CEO Manna buys 2,000 shares at $6.47; stock down 35.9% from 52-week high; prior 5 trades at this ticker all well-timed on 90d basis.

CEO Michael Edward Manna purchased 2,000 shares of Ultralife at $6.47 on 2026-05-18, expanding his holdings from 26,674 to 28,674 shares. The purchase occurs as the stock trades -35.9% from its 52-week high and is down 21.1% over the last 30 days, creating a contrarian buying signal. Notably, Manna's prior 5 trades at Ultralife were all well-timed at the 90-day mark (with 90d returns ranging from +0.6% to +28.5%), suggesting a consistent pattern of purchasing at strategically favorable entry points. However, context matters: the company remains unprofitable (net income $-451,000 in the latest quarter despite $47.4M in revenue and 16.2% annual revenue growth), and the stock has declined 1.9% over 90 days, meaning this purchase occurs in a materially different environment than his prior successes at this ticker.